Schroder Investment Management Group Kal Vista Pharmaceuticals, Inc. Transaction History
Schroder Investment Management Group
- $112 Billion
- Q2 2025
A detailed history of Schroder Investment Management Group transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 554,958 shares of KALV stock, worth $6.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
554,958
Previous 868,011
36.07%
Holding current value
$6.8 Million
Previous $10 Million
37.34%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding KALV
# of Institutions
146Shares Held
54.1MCall Options Held
986KPut Options Held
90.1K-
Vr Adviser, LLC New York, NY6.73MShares$82.4 Million15.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.96MShares$60.7 Million1.93% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$60.5 Million3.35% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$59.9 Million2.92% of portfolio
-
Vestal Point Capital, LP New York, NY4.68MShares$57.3 Million2.78% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $301M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...